Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. · 2021
Read Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. by Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8199012.txt.
Description
Infantino and co-authors explain cancer cell metabolism under low oxygen, with HIF-1 at the centre. Cancer cells rewire fuel use to meet high energy demand. Tumour zones often lack oxygen, though it is key for energy making.
The factor HIF-1 directs how cells adapt to that shortage. Mitochondria and HIF-1 trade signals that reset cell function. The review sums up the molecular steps in this rewiring. It shows how the shift helps tumours survive. HIF-1 stands out as a drug target. Blocking it could starve the adaptation itself. That hub is the mitochondrion, as the authors stress.
Catalog record
| CREATOR | Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |